logo

(877) 920-9009
ABSOLUTELY NO COST TO YOU UNLESS WE WIN

Dangerous Drugs Blog

Actos Link to Bladder Cancer Confirmed by the FDA

In December, the U.S. Food and Drug Administration (FDA) confirmed that taking the type 2 diabetes drug pioglitazone, also known as Actos, can increase patients' risk of developing bladder cancer. The FDA announced this conclusion in a drug safety communication,… Read More

Takeda Pharmaceutical Co. Agrees to Pay More than $2.3 Billion to Settle Actos Lawsuits

After 9,000 lawsuits having been filed against them, Takeda Pharmaceutical Co. has agreed to pay $2.37 billion to resolve claims that the popular diabetes drug Actos causes bladder cancer.Actos was introduced into the market in 1999 to treat diabetes,and… Read More

Benicar® Labels to Include Risk of Adverse Cardiac Events, FDA Says

The hypertension medication Benicar has been linked to increased risk of heart attack and stroke in patients with type 2 diabetes, a clinical study suggests. Now, the U.S. Food and Drug Administration (FDA) has announced a mandatory change to the drugs… Read More